95 filings
Page 3 of 5
8-K
i02bp
13 May 20
Submission of Matters to a Vote of Security Holders
4:00pm
8-K
kdf5i24eft3qa4 96b
23 Apr 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:03am
8-K
r4dcb96ttcz
17 Mar 20
Novus Therapeutics Reports Fourth Quarter and Full-Year 2019 Financial Results
6:03am
8-K/A
qyj4fmp
20 Feb 20
Unregistered Sales of Equity Securities
6:12am
8-K
62bmp7iyq42t03
19 Feb 20
Unregistered Sales of Equity Securities
4:11pm
8-K
e4lxaz
7 Feb 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
dnfmz 13qtn0ws6uxt
16 Jan 20
Entry into a Material Definitive Agreement
6:32am
8-K
0lbhn56jrat
13 Nov 19
Novus Therapeutics Reports Third Quarter 2019 Financial Results
6:00am
8-K
ozeqn4py2unn6h8 y7
13 Aug 19
Novus Therapeutics Reports Second Quarter 2019 Financial Results
4:37pm
8-K
3m8ako aq
9 Aug 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:30pm
8-K
dab bvrbv3v39
12 Jul 19
Changes in Registrant's Certifying Accountant
4:05pm
8-K
vvm9p0c2 32ymv3g5tb4
14 May 19
Novus Therapeutics Reports First Quarter 2019 Financial Results
4:30pm
8-K
5hqr5n
2 May 19
Novus Therapeutics Announces $10.7 Million Registered Direct Offering PricedAt-the-Market
4:24pm
8-K
kswd2lt r4
22 Apr 19
Novus Therapeutics Announces Results of Two Single-Dose Phase 1 Studies of OP0201
8:02am
8-K
jcg3utg
28 Mar 19
Novus Therapeutics Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides Clinical Updates
6:04am
8-K
qhdhow1d1u l29tclg
8 Jan 19
Regulation FD Disclosure
12:49pm
8-K
qzfok
13 Nov 18
Novus Therapeutics Reports Third Quarter 2018 Financial Results
7:58am
8-K
kqny53f
7 Aug 18
Novus Therapeutics Reports Second Quarter 2018 Financial Results
8:31am
8-K
x2nk fk4lydllp
14 Jun 18
Submission of Matters to a Vote of Security Holders
12:00am
8-K
rzupyhupryidit qy
11 May 18
Novus Therapeutics Reports First Quarter 2018 Financial Results
12:00am